№ lp_1_00315
File format: docx
Character count: 13893
File size: 145 KB
This document presents supplementary tables and data extraction guidelines related to a systematic review on COVID-19 vaccination during pregnancy, including information on study characteristics, outcomes, and exclusions.
Year:
2021
Country:
Global
Topic:
COVID-19 vaccination during pregnancy
Document Type:
Supplementary material
Study Type:
Systematic review
Authors:
Not specified
Target Audience:
Researchers, healthcare professionals, policy makers
Period of validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2023
Region / City:
United Kingdom
Topic:
Medical Testing, Pregnancy Detection
Document Type:
Standard Operating Procedure (SOP)
Organization:
POCT
Author:
Rachel Lampard
Target Audience:
Clinical Staff
Approval Date:
N/A
Review Interval:
2 years
Changes from last version:
First entry to Q-pulse
Date of Approval:
N/A
Date of Changes:
N/A
Type of document:
Official information for health professionals
Topic:
Respiratory syncytial virus vaccination in pregnancy
Vaccine name:
Abrysvo®
Target population:
Pregnant women
Gestational age for administration:
28–36 weeks of pregnancy
Country:
Australia
Health program:
National Immunisation Program
Availability under NIP:
From 3 February 2025
Notifiable disease status:
RSV notifiable in Victoria since 22 February 2022
Regulatory authority:
Therapeutic Goods Administration
Monitoring scheme:
Black Triangle Scheme
Related legislation:
Public Health and Wellbeing Act 2008
Intended audience:
Health professionals
Storage requirements:
+2°C to +8°C
Year:
2017
Region / City:
Washington, DC
Theme:
Public Health, Health IT, Zika Virus
Document Type:
Report
Organization / Institution:
Health IT Policy Committee (HITPC), Health IT Standards Committee (HITSC), Department of Health and Human Services
Author:
Public Health Task Force
Target Audience:
Public health professionals, health IT developers, clinicians
Period of Effectiveness:
2017
Approval Date:
March 8, 2017
Date of Changes:
Not specified
Year:
2019
Region / City:
N/A
Subject:
Pregnancy tracking in Treatment Episode Data Set
Document Type:
Requirements Document
Organization:
DCF
Author:
Jesse Lindsey
Target Audience:
FEI Business Analysts, DCF SAMH Project Team
Period of Validity:
N/A
Approval Date:
03/17/2019
Modification Date:
03/21/2019
Year:
2021
Region / city:
Australian Capital Territory
Topic:
Hypertension, Pregnancy, Maternity Care
Document Type:
Guideline
Author:
Canberra Health Services
Target Audience:
Medical officers, Registered Midwives, Nurses, Allied Health professionals, Students working under supervision
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2024
Region / City:
Canberra
Topic:
Diabetes Management in Pregnancy
Document Type:
Guideline
Organization:
Canberra Health Services
Author:
Australasian Diabetes in Pregnancy Society (ADIPS)
Target Audience:
Healthcare providers (medical officers, nurses, midwives)
Period of validity:
Not specified
Approval Date:
Not specified
Date of last update:
November 2024
Year:
2023
Region / city:
Canberra, Australia
Topic:
Obstetrics, Pre-eclampsia, Pregnancy Care
Document type:
Guideline
Organization / institution:
Canberra Health Services
Author:
Society of Obstetric Medicine Australia and New Zealand (SOMANZ)
Target audience:
Medical Officers, Registered Nurses, Registered Midwives, Students, Pharmacists
Period of validity:
Not specified
Approval date:
2023
Date of amendments:
Not specified
Year:
2026
Location:
North Canberra Hospital, Canberra, Australia
Document type:
Procedure
Department:
Canberra Health Services – Maternity Unit and Medical Imaging
Audience:
Medical Officers, Nurses, Midwives, Medical Imaging staff
Scope:
Pregnancy ultrasound eligibility and bedside ultrasound use in maternity care
Attachments:
CHS Preterm Birth Prevention – Management of Moderate-Risk Patients Pathway; Fetal Growth Restriction (FGR) care pathway for singleton pregnancies
Related policies:
Maternal Fetal Medicine Unit referrals, clinical guidelines for prenatal imaging
Reference:
CHS25/004 Procedure Document
Note:
Year
Topic:
Medical Diagnostics
Document Type:
Standard Operating Procedure (SOP)
Organization:
Siemens
Author:
Jane Mason
Target Audience:
Medical professionals
Period of Use:
Indefinite
Year:
2023
Region / City:
United Kingdom
Topic:
Student support, maternity, pregnancy
Document Type:
Policy
Institution:
University of Oxford
Author:
Not specified
Target Audience:
Students, academic staff
Period of Validity:
Ongoing
Approval Date:
Not specified
Date of Amendments:
Not specified
Year:
2023
Region / City:
Canberra
Topic:
Obesity and its impact on pregnancy and childbirth
Document Type:
Guideline
Organization:
Canberra Health Services
Author:
Not specified
Target Audience:
Medical Officers, Registered Midwives, Students under direct supervision
Effective Period:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / City:
Canberra
Topic:
Hyperemesis Gravidarum, Pregnancy Care
Document Type:
Procedure
Organization:
Canberra Health Services
Author:
Not specified
Target Audience:
Clinical staff at CHS, external referrers, medical and nursing professionals
Period of Application:
Ongoing
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2025
Document type:
Job specification and recruitment notice
Job title:
Clinical Midwife Specialist Early Pregnancy Loss / Clinical Nurse Specialist Early Pregnancy Loss
Grade codes:
CMS 2313; CNS 2632
Salary scale:
€61,463–€77,666 LSI (as of 01/08/2025)
Employment type:
Permanent whole-time vacancy; panel for full-time and part-time posts
Department:
Maternity Department
Location:
Sligo University Hospital, Sligo, Ireland
Organisation:
Health Service Executive, West and North West Region
Campaign reference:
SLIGO0647
Closing date:
December 15, 2025
Interview timeframe:
As soon as possible after closing date
Reporting to:
Director of Midwifery / Assistant Director of Midwifery
Service region:
West and North West of Ireland
Target population:
Women experiencing early pregnancy complications
Source type:
Official health service recruitment documentation
Year:
2024
Region / City:
United Kingdom
Subject:
Doxycycline use during pregnancy
Document type:
Position statement
Organization / Institution:
BASHH (British Association for Sexual Health and HIV)
Author:
Ali Grant; on behalf of BASHH Clinical Effectiveness Group (CEG)
Target audience:
Healthcare professionals
Effective period:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Year:
2026
Region / city:
Massachusetts
Topic:
Health Care Personnel Vaccination
Document Type:
Report
Agency / Organization:
Massachusetts Department of Public Health
Author:
Massachusetts Department of Public Health
Target Audience:
Health Care Personnel, Licensed Facilities in Massachusetts
Period of Validity:
Oct 1 2025 - Mar 31 2026
Approval Date:
N/A
Date of Last Update:
N/A
Type of document:
Official information for health professionals
Topic:
Respiratory syncytial virus vaccination in pregnancy
Vaccine name:
Abrysvo®
Target population:
Pregnant women
Gestational age for administration:
28–36 weeks of pregnancy
Country:
Australia
Health program:
National Immunisation Program
Availability under NIP:
From 3 February 2025
Notifiable disease status:
RSV notifiable in Victoria since 22 February 2022
Regulatory authority:
Therapeutic Goods Administration
Monitoring scheme:
Black Triangle Scheme
Related legislation:
Public Health and Wellbeing Act 2008
Intended audience:
Health professionals
Storage requirements:
+2°C to +8°C
Business Rules for Quality and Outcomes Framework (QOF) 2023/2024/24-25 Vaccination and Immunisation
Note:
Author
Version Date:
01/04/2023–01/04/2024
Version:
48.049.0
Year:
2023
Region / City:
England
Subject:
Quality and Outcomes Framework, Vaccination, Immunisation
Document Type:
Guidelines
Organization:
NHS England
Author:
General Practice Specification and Extraction Service (GPSES)
Target Audience:
GP Practices, GP System Suppliers, NHS England
Effective Period:
01/04/2023 – 31/03/2025
Approval Date:
01/04/2023
Amendment History Date:
01/04/2021, 01/04/2022, 01/04/2023
Supporting Documents:
Version 1.6 of the supporting information document
Reference Documents:
NHS Digital TRUD, Primary Care Domain Reference Set Portal
Note:
Year
Topic:
Immunisation Training
Document Type:
Competency Assessment
Target Audience:
Health care professionals in training
Year:
2023
Region / City:
Australia
Topic:
Japanese encephalitis vaccination
Document Type:
Consent form
Organization / Institution:
Australian Government
Author:
Unknown
Target Audience:
Individuals receiving JE vaccination
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified